Theravance Biopharma (TBPH) Current Assets (2013 - 2026)
Theravance Biopharma (TBPH) posted Current Assets of $416.66 million for Q2 2026, up 13.8% from $366.29 million a year earlier but down 0.2% from the prior quarter.
Theravance Biopharma (TBPH) Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Theravance Biopharma's Current Assets came in at $418.46 million, up 159.8% from FY2024.
- Annual Current Assets shows a five-year compound annual growth rate of 1.2% (FY2020 to FY2025).
- In prior years, Theravance Biopharma's Current Assets was $161.07 million in FY2024 (+20.6%), $133.54 million in FY2023 (-62.2%), $353.46 million in FY2022 (+41.5%) and $249.87 million in FY2021 (-36.5%).
- Quarterly Current Assets has run from a low of $116.48 million in Q3 2024 to a high of $511.72 million in Q3 2022 over five years.
- On a year-over-year basis, Current Assets has increased in each of the last seven quarters, with growth averaging 97.1% over the last eight quarters.
- The strongest year-over-year quarter for Current Assets in the past five years was Q2 2025, with growth of 207.0%; the weakest was Q3 2023, with a decline of 68.4%.
- According to Business Quant data, Current Assets for the three prior quarters was $417.63 million (Q1 2026), $418.46 million (Q4 2025) and $354.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | 416.66 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 416.66 Mn |
| Mar 31, 2026 | 417.63 Mn |
| Dec 31, 2025 | 418.46 Mn |
| Sep 30, 2025 | 354.70 Mn |
| Jun 30, 2025 | 366.29 Mn |
| Mar 31, 2025 | 150.26 Mn |
| Dec 31, 2024 | 161.07 Mn |
| Sep 30, 2024 | 116.48 Mn |
| Jun 30, 2024 | 119.31 Mn |
| Mar 31, 2024 | 124.29 Mn |
| Dec 31, 2023 | 133.54 Mn |
| Sep 30, 2023 | 161.69 Mn |
| Jun 30, 2023 | 192.00 Mn |
| Mar 31, 2023 | 261.34 Mn |
| Dec 31, 2022 | 353.46 Mn |
| Sep 30, 2022 | 511.72 Mn |
| Jun 30, 2022 | 154.73 Mn |
| Mar 31, 2022 | 204.64 Mn |
| Dec 31, 2021 | 249.87 Mn |
| Sep 30, 2021 | 297.17 Mn |
Theravance Biopharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=TBPH&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();